Charles Pauling Semba - 15 Jul 2021 Form 3 Insider Report for DiaMedica Therapeutics Inc. (DMAC)

Role
Director
Signature
/s/ Amy Culbert, attorney-in-fact
Issuer symbol
DMAC
Transactions as of
15 Jul 2021
Net transactions value
$0
Form type
3
Filing time
16 Jul 2021, 16:16:06 UTC
Next filing
02 Jun 2022

No securities are beneficially owned.